A REVIEW ON EXPLORING THE MEDICINAL VALUE OF ZINGIBER OFFICINALE AND HYOSCYAMUS NIGER TO PREVENT OR OVERCOME SEASICKNESS
Main Article Content
Keywords
.
Abstract
Motion sickness (MS) is a common complication of traveling by sea, air, or land. It is characterized by a variety of symptoms, including headaches, eye strain, difficulty focusing, blurred vision, and headaches. Several studies have identified the role of genetic variations in the pathogenesis of motion sickness. In this article the study is completed focused on the Pharmacognostical and pharmacological aspects of the Zingiber officinale and Hyoscyamus niger, a medicinal plant with a long history of use.
References
1. Irwin JA. THE PATHOLOGY OF SEA-SICKNESS. The Lancet. 1881 Nov 26;118(3039):907-9.
2. Lawther A, Griffin MJ. A survey of the occurrence of motion sickness amongst passengers at sea. Aviation, space, and environmental medicine. 1988 May 1;59(5):399-406.
3. McCauley ME, Sharkey TJ. Cybersickness: Perception of self-motion in virtual environments. Presence: Teleoperators & Virtual Environments. 1992 Aug 1;1(3):311-8.
4. Brooks JO, Goodenough RR, Crisler MC, Klein ND, Alley RL, Koon BL, Logan Jr WC, Ogle JH, Tyrrell RA, Wills RF. Simulator sickness during driving simulation studies. Accident analysis & prevention. 2010 May 1;42(3):788-96.
5. Davis S, Nesbitt K, Nalivaiko E. A systematic review of cybersickness. In Proceedings of the 2014 conference on interactive entertainment 2014 Dec 2 (pp. 1-9).
6. LaViola Jr JJ. A discussion of cybersickness in virtual environments. ACM Sigchi Bulletin. 2000 Jan 1;32(1):47-56.
7. Kennedy RS, Lane NE, Berbaum KS, Lilienthal MG. Simulator sickness questionnaire: An enhanced method for quantifying simulator sickness. The international journal of aviation psychology. 1993 Jul 1;3(3):203-20.
8. Rhode J, Fogoros S, Zick S, Wahl H, Griffith KA, Huang J, Liu JR. Ginger inhibits cell growth and modulates angiogenic factors in ovarian cancer cells. BMC complementary and Alternative Medicine. 2007 Dec;7:1-9.
9. Poeloengan M. The effect of red ginger (Zingiber officinale Roscoe) extract on the growth of mastitis causing bacterial isolates. African Journal of Microbiology Research. 2011 Feb 18;5(4):382-9.
10. Kadi K, Yahia A, Hamli S, Auidane L, Khabthane H, Ali WK. In vitro antibacterial activity and phytochemical analysis of White henbane treated by phytohormones. Pakistan Journal of Biological Sciences: PJBS. 2013 Oct 1;16(19):984-90.
11. Ma CY, Liu WK, Che CT. Lignanamides and nonalkaloidal components of Hyoscyamus n iger seeds. Journal of natural products. 2002 Feb 22;65(2):206-9.
12. Gilani AH, Khan AU, Raoof M, Ghayur MN, Siddiqui BS, Vohra W, Begum S. Gastrointestinal, selective airways and urinary bladder relaxant effects of Hyoscyamus niger are mediated through dual blockade of muscarinic receptors and Ca2+ channels. Fundamental & Clinical Pharmacology. 2008 Feb;22(1):87-99.
13. Khan AU, Gilani AH. Cardiovascular inhibitory effects of Hyoscyamus niger. Methods and findings in experimental and clinical pharmacology. 2008 May 1;30(4):295-300.
14. Begum S, Saxena B, Goyal M, Ranjan R, Joshi VB, Rao CV, Krishnamurthy S, Sahai M. Study of anti-inflammatory, analgesic and antipyretic activities of seeds of Hyoscyamus niger and isolation of a new coumarinolignan. Fitoterapia. 2010 Apr 1;81(3):178-84.
15. Vallabi DE, Elango V. Preliminary studies on cardio protective effect of Hyoscyamus niger Linn in male albino rats. J Chem Pharm Res. 2016 Aug 10;8(7):860-4.
16. Paulsen BS. Highlights through the history of plant medicine. Bioactive compounds in plants-benefits and risks for man and animals. 2010;50.
17 Dey KL, Bahadur R, Mair W. Indigenous Drugs of India. New Delhi: Pama Primalane, The Chronia Botanica; 1973. p. 160.
18. Li R, Reed DW, Liu E, Nowak J, Pelcher LE, Page JE, Covello PS. Functional genomic analysis of alkaloid biosynthesis in Hyoscyamus niger reveals a cytochrome P450 involved in littorine rearrangement. Chemistry & Biology. 2006 May 1;13(5):513-20.
19. Bernhoft AJ. A brief review on bioactive compounds in plants. Bioactive compounds in plants-benefits and risks for man and animals. 2010;50:11-7.
20. Sajeli B, Sahai M, Suessmuth R, Asai T, Hara N, Fujimoto Y. Hyosgerin, a new optically active coumarinolignan, from the seeds of Hyoscyamus niger. Chemical and pharmaceutical bulletin. 2006;54(4):538-41.
21. Ma CY, Liu WK, Che CT. The flowering hormones. Ber Dtsch Bot Ges 2002;57:29-48.
22. Azhar M. Phytopharmacology of an important unani drug Bazr-Ul-Banj (Hyoscyamus Niger Linn.)-Review. Asian Journal of Pharmaceutical and Clinical Research. 2020 Sep;13(9):28-32.
23. Vella K. Investigation of the alkaloidal content of local hyoscyamus albus l.
24. Daneshvar S, Mirhossaini ME, Balali-Mood M. Hyoscyamus poisoning in Mashhad. Toxicon. 1992 ;30:501.
25 Graham and Johnson, 2010
26 Grieve M. A Modern Herbal. 1913.http://botanical.com/botanical/mgmh/h/henban23.html.
27 Saeed S, Tariq P. PHARMACOLOGICAL ACTIVITIES OF GINGER (ZINGIBER OFFICINALE): A REVIW.
28 Shupak A, Gordon CR. Motion sickness: advances in pathogenesis, prediction, prevention, and treatment. Aviation, space, and environmental medicine. 2006 Dec 1;77(12):1213-23.
29) Koohestani A, Nahavandi D, Asadi H, Kebria PM, Khosravi A, Alizadehsani R, Nahavandi S. A knowledge discovery in motion sickness: a comprehensive literature review. IEEE access. 2019 Jun 14 ;7:85755-70
30)Walker AD, Muth ER, Switzer FS, Hoover A. Head movements and simulator sickness generated by a virtual environment. Aviation, space, and environmental medicine. 2010 Oct 1;81(10):929-34.
31)Lawther A, Griffin MJ. A survey of the occurrence of motion sickness amongst passengers at sea. Aviation, space, and environmental medicine. 1988 May 1;59(5):399-406.
32) Ma CY, Liu WK, Che CT. The flowering hormones. Ber Dtsch Bot Ges 2002;57:29-48.
33)Mishra BB, Gautam S, Sharma A. Shelf‐Life Extension of Fresh Ginger (Zingiber officinale) by Gamma Irradiation. Journal of food science. 2004 Dec;69(9):M274-9.
34)Shadmani A, Azhar I, Mazhar FA, Hassan MM, Ahmed SW, Ahmad I, Usmanghani K, Shamim S. Kinetic studies on Zingiber officinale. Pakistan journal of pharmaceutical sciences. 2004 Jan 1;17(1):47-54.
35)Wang CC, Chen LG, Lee LT, Yang LL. Effects of 6-gingerol, an antioxidant from ginger, on inducing apoptosis in human leukemic HL-60 cells. In vivo (Athens, Greece). 2003 Nov 1;17(6):641-5.
36)Mahady GB, Pendland SL, Yun GS, Lu ZZ, Stoia A. Ginger (Zingiber officinale Roscoe) and the gingerols inhibit the growth of Cag A+ strains of Helicobacter pylori. Anticancer research. 2003 Sep ;23:3699.
37)Nurtjahja-Tjendraputra E, Ammit AJ, Roufogalis BD, Tran VH, Duke CC. Effective anti-platelet and COX-1 enzyme inhibitors from pungent constituents of ginger. Thrombosis research. 2003 Jan 1;111(4-5):259-65.
38)GUH JH, KO FN, JONG TT, TENG CM. Antiplatelet effect of gingerol isolated from Zingiber officinale. Journal of Pharmacy and Pharmacology. 1995 Apr;47(4):329-32.
39)Bhattarai S, Duke CC. The stability of gingerol and shogaol in aqueous solutions. Journal of pharmaceutical sciences. 2001 Oct 1;90(10):1658-64.
40)Yamahara J, Rong HQ, Iwamoto M, Kobayashi G, Matsuda H, Fujimura H. Active components of ginger exhibiting anti‐serotonergic action. Phytotherapy Research. 1989;3(2):70-1
41)HUANG Q, IWAMOTO M, AOKI S, TANAKA N, TAJIMA K, YAMAHARA J, TAKAISHI Y, YOSHIDA M, TOMIMATSU T, TAMAI Y. Anti-5-hydroxytryptamine3 effect of galanolactone, diterpenoid isolated from ginger. Chemical and pharmaceutical bulletin. 1991 Feb 25;39(2):397-9.
42)Fuhrman B, Rosenblat M, Hayek T, Coleman R, Aviram M. Ginger extract consumption reduces plasma cholesterol, inhibits LDL oxidation and attenuates development of atherosclerosis in atherosclerotic, apolipoprotein E-deficient mice. The Journal of nutrition. 2000 May 1;130(5):1124-31.
43)Park M, Bae J, Lee DS. Antibacterial activity of [10]‐gingerol and [12]‐gingerol isolated from ginger rhizome against periodontal bacteria. Phytotherapy Research: An International Journal Devoted to Pharmacological and Toxicological Evaluation of Natural Product Derivatives. 2008 Nov;22(11):1446-9.
44)Al-Yahya MA, Rafatullah S, Mossa JS, Ageel AM, Parmar NS, Tariq M. Gastroprotective activity of ginger zingiber officinale rosc., in albino rats. Am J Chin Med. 1989 Jan 1;17(1-2):51-6.
45)Thomson M, Al-Qattan KK, Al-Sawan SM, Alnaqeeb MA, Khan I, Ali M. The use of ginger (Zingiber officinale Rosc.) as a potential anti-inflammatory and antithrombotic agent. Prostaglandins, leukotrienes and essential fatty acids. 2002 Dec 1;67(6):475-8.
46)Mahady GB, Pendland SL, Yun GS, Lu ZZ, Stoia A. Ginger (Zingiber officinale Roscoe) and the gingerols inhibit the growth of Cag A+ strains of Helicobacter pylori. Anticancer research. 2003 Sep;23:3699
47)Bhandari U, Sharma JN, Zafar R. The protective action of ethanolic ginger (Zingiber officinale) extract in cholesterol fed rabbits. Journal of Ethnopharmacology. 1998 Jun 1;61(2):167-71.
48)Nurtjahja-Tjendraputra E, Ammit AJ, Roufogalis BD, Tran VH, Duke CC. Effective anti-platelet and COX-1 enzyme inhibitors from pungent constituents of ginger. Thrombosis research. 2003 Jan 1;111(4-5):259-65.
49) B. J Yates,1* A.D. Miller2 and J. B. Lucot3, “Department of otolaryngology and Neuroscience”,“Physiological basis and pharmacology of motion sickness” 28 April 1998.
50) Sharma Y. Ginger (Zingiber officinale)-an elixir of life a review. The Pharma Innovation. 2017 Nov 1;6(11, Part A):22.
51) Brown AC, Shah C, Liu J, Pham JT, Zhang JG, Jadus MR. Ginger's (Zingiber officinale Roscoe) inhibition of rat colonic adenocarcinoma cells proliferation and angiogenesis in vitro. Phytotherapy Research: An International Journal Devoted to Pharmacological and Toxicological Evaluation of Natural Product Derivatives. 2009 May;23(5):640-5.
52) Syafitri DM, Levita J, Mutakin M, Diantini A. A review: Is ginger (Zingiber officinale var. Roscoe) potential for future phytomedicine. Indonesian Journal of Applied Sciences. 2018 Apr 30;8(1):8-13.
53)Paulsen BS. Highlights through the history of plant medicine. Bioactive compounds in plants-benefits and risks for man and animals. 2010;50.
54)Li R, Reed DW, Liu E, Nowak J, Pelcher LE, Page JE, Covello PS. Functional genomic analysis of alkaloid biosynthesis in Hyoscyamus niger reveals a cytochrome P450 involved in littorine rearrangement. Chemistry & Biology. 2006 May 1;13(5):513-20.
55)Bernhoft AJ. A brief review on bioactive compounds in plants. Bioactive compounds in plants-benefits and risks for man and animals. 2010;50:11-7.
56)Begum Sajeli BS, Mahendra Sahai MS, Suessmuth R, Asai T, Hara N, Fujimoto Y. Hyosgerin, a new optically active coumarinolignan, from the seeds of Hyoscyamus niger.
2. Lawther A, Griffin MJ. A survey of the occurrence of motion sickness amongst passengers at sea. Aviation, space, and environmental medicine. 1988 May 1;59(5):399-406.
3. McCauley ME, Sharkey TJ. Cybersickness: Perception of self-motion in virtual environments. Presence: Teleoperators & Virtual Environments. 1992 Aug 1;1(3):311-8.
4. Brooks JO, Goodenough RR, Crisler MC, Klein ND, Alley RL, Koon BL, Logan Jr WC, Ogle JH, Tyrrell RA, Wills RF. Simulator sickness during driving simulation studies. Accident analysis & prevention. 2010 May 1;42(3):788-96.
5. Davis S, Nesbitt K, Nalivaiko E. A systematic review of cybersickness. In Proceedings of the 2014 conference on interactive entertainment 2014 Dec 2 (pp. 1-9).
6. LaViola Jr JJ. A discussion of cybersickness in virtual environments. ACM Sigchi Bulletin. 2000 Jan 1;32(1):47-56.
7. Kennedy RS, Lane NE, Berbaum KS, Lilienthal MG. Simulator sickness questionnaire: An enhanced method for quantifying simulator sickness. The international journal of aviation psychology. 1993 Jul 1;3(3):203-20.
8. Rhode J, Fogoros S, Zick S, Wahl H, Griffith KA, Huang J, Liu JR. Ginger inhibits cell growth and modulates angiogenic factors in ovarian cancer cells. BMC complementary and Alternative Medicine. 2007 Dec;7:1-9.
9. Poeloengan M. The effect of red ginger (Zingiber officinale Roscoe) extract on the growth of mastitis causing bacterial isolates. African Journal of Microbiology Research. 2011 Feb 18;5(4):382-9.
10. Kadi K, Yahia A, Hamli S, Auidane L, Khabthane H, Ali WK. In vitro antibacterial activity and phytochemical analysis of White henbane treated by phytohormones. Pakistan Journal of Biological Sciences: PJBS. 2013 Oct 1;16(19):984-90.
11. Ma CY, Liu WK, Che CT. Lignanamides and nonalkaloidal components of Hyoscyamus n iger seeds. Journal of natural products. 2002 Feb 22;65(2):206-9.
12. Gilani AH, Khan AU, Raoof M, Ghayur MN, Siddiqui BS, Vohra W, Begum S. Gastrointestinal, selective airways and urinary bladder relaxant effects of Hyoscyamus niger are mediated through dual blockade of muscarinic receptors and Ca2+ channels. Fundamental & Clinical Pharmacology. 2008 Feb;22(1):87-99.
13. Khan AU, Gilani AH. Cardiovascular inhibitory effects of Hyoscyamus niger. Methods and findings in experimental and clinical pharmacology. 2008 May 1;30(4):295-300.
14. Begum S, Saxena B, Goyal M, Ranjan R, Joshi VB, Rao CV, Krishnamurthy S, Sahai M. Study of anti-inflammatory, analgesic and antipyretic activities of seeds of Hyoscyamus niger and isolation of a new coumarinolignan. Fitoterapia. 2010 Apr 1;81(3):178-84.
15. Vallabi DE, Elango V. Preliminary studies on cardio protective effect of Hyoscyamus niger Linn in male albino rats. J Chem Pharm Res. 2016 Aug 10;8(7):860-4.
16. Paulsen BS. Highlights through the history of plant medicine. Bioactive compounds in plants-benefits and risks for man and animals. 2010;50.
17 Dey KL, Bahadur R, Mair W. Indigenous Drugs of India. New Delhi: Pama Primalane, The Chronia Botanica; 1973. p. 160.
18. Li R, Reed DW, Liu E, Nowak J, Pelcher LE, Page JE, Covello PS. Functional genomic analysis of alkaloid biosynthesis in Hyoscyamus niger reveals a cytochrome P450 involved in littorine rearrangement. Chemistry & Biology. 2006 May 1;13(5):513-20.
19. Bernhoft AJ. A brief review on bioactive compounds in plants. Bioactive compounds in plants-benefits and risks for man and animals. 2010;50:11-7.
20. Sajeli B, Sahai M, Suessmuth R, Asai T, Hara N, Fujimoto Y. Hyosgerin, a new optically active coumarinolignan, from the seeds of Hyoscyamus niger. Chemical and pharmaceutical bulletin. 2006;54(4):538-41.
21. Ma CY, Liu WK, Che CT. The flowering hormones. Ber Dtsch Bot Ges 2002;57:29-48.
22. Azhar M. Phytopharmacology of an important unani drug Bazr-Ul-Banj (Hyoscyamus Niger Linn.)-Review. Asian Journal of Pharmaceutical and Clinical Research. 2020 Sep;13(9):28-32.
23. Vella K. Investigation of the alkaloidal content of local hyoscyamus albus l.
24. Daneshvar S, Mirhossaini ME, Balali-Mood M. Hyoscyamus poisoning in Mashhad. Toxicon. 1992 ;30:501.
25 Graham and Johnson, 2010
26 Grieve M. A Modern Herbal. 1913.http://botanical.com/botanical/mgmh/h/henban23.html.
27 Saeed S, Tariq P. PHARMACOLOGICAL ACTIVITIES OF GINGER (ZINGIBER OFFICINALE): A REVIW.
28 Shupak A, Gordon CR. Motion sickness: advances in pathogenesis, prediction, prevention, and treatment. Aviation, space, and environmental medicine. 2006 Dec 1;77(12):1213-23.
29) Koohestani A, Nahavandi D, Asadi H, Kebria PM, Khosravi A, Alizadehsani R, Nahavandi S. A knowledge discovery in motion sickness: a comprehensive literature review. IEEE access. 2019 Jun 14 ;7:85755-70
30)Walker AD, Muth ER, Switzer FS, Hoover A. Head movements and simulator sickness generated by a virtual environment. Aviation, space, and environmental medicine. 2010 Oct 1;81(10):929-34.
31)Lawther A, Griffin MJ. A survey of the occurrence of motion sickness amongst passengers at sea. Aviation, space, and environmental medicine. 1988 May 1;59(5):399-406.
32) Ma CY, Liu WK, Che CT. The flowering hormones. Ber Dtsch Bot Ges 2002;57:29-48.
33)Mishra BB, Gautam S, Sharma A. Shelf‐Life Extension of Fresh Ginger (Zingiber officinale) by Gamma Irradiation. Journal of food science. 2004 Dec;69(9):M274-9.
34)Shadmani A, Azhar I, Mazhar FA, Hassan MM, Ahmed SW, Ahmad I, Usmanghani K, Shamim S. Kinetic studies on Zingiber officinale. Pakistan journal of pharmaceutical sciences. 2004 Jan 1;17(1):47-54.
35)Wang CC, Chen LG, Lee LT, Yang LL. Effects of 6-gingerol, an antioxidant from ginger, on inducing apoptosis in human leukemic HL-60 cells. In vivo (Athens, Greece). 2003 Nov 1;17(6):641-5.
36)Mahady GB, Pendland SL, Yun GS, Lu ZZ, Stoia A. Ginger (Zingiber officinale Roscoe) and the gingerols inhibit the growth of Cag A+ strains of Helicobacter pylori. Anticancer research. 2003 Sep ;23:3699.
37)Nurtjahja-Tjendraputra E, Ammit AJ, Roufogalis BD, Tran VH, Duke CC. Effective anti-platelet and COX-1 enzyme inhibitors from pungent constituents of ginger. Thrombosis research. 2003 Jan 1;111(4-5):259-65.
38)GUH JH, KO FN, JONG TT, TENG CM. Antiplatelet effect of gingerol isolated from Zingiber officinale. Journal of Pharmacy and Pharmacology. 1995 Apr;47(4):329-32.
39)Bhattarai S, Duke CC. The stability of gingerol and shogaol in aqueous solutions. Journal of pharmaceutical sciences. 2001 Oct 1;90(10):1658-64.
40)Yamahara J, Rong HQ, Iwamoto M, Kobayashi G, Matsuda H, Fujimura H. Active components of ginger exhibiting anti‐serotonergic action. Phytotherapy Research. 1989;3(2):70-1
41)HUANG Q, IWAMOTO M, AOKI S, TANAKA N, TAJIMA K, YAMAHARA J, TAKAISHI Y, YOSHIDA M, TOMIMATSU T, TAMAI Y. Anti-5-hydroxytryptamine3 effect of galanolactone, diterpenoid isolated from ginger. Chemical and pharmaceutical bulletin. 1991 Feb 25;39(2):397-9.
42)Fuhrman B, Rosenblat M, Hayek T, Coleman R, Aviram M. Ginger extract consumption reduces plasma cholesterol, inhibits LDL oxidation and attenuates development of atherosclerosis in atherosclerotic, apolipoprotein E-deficient mice. The Journal of nutrition. 2000 May 1;130(5):1124-31.
43)Park M, Bae J, Lee DS. Antibacterial activity of [10]‐gingerol and [12]‐gingerol isolated from ginger rhizome against periodontal bacteria. Phytotherapy Research: An International Journal Devoted to Pharmacological and Toxicological Evaluation of Natural Product Derivatives. 2008 Nov;22(11):1446-9.
44)Al-Yahya MA, Rafatullah S, Mossa JS, Ageel AM, Parmar NS, Tariq M. Gastroprotective activity of ginger zingiber officinale rosc., in albino rats. Am J Chin Med. 1989 Jan 1;17(1-2):51-6.
45)Thomson M, Al-Qattan KK, Al-Sawan SM, Alnaqeeb MA, Khan I, Ali M. The use of ginger (Zingiber officinale Rosc.) as a potential anti-inflammatory and antithrombotic agent. Prostaglandins, leukotrienes and essential fatty acids. 2002 Dec 1;67(6):475-8.
46)Mahady GB, Pendland SL, Yun GS, Lu ZZ, Stoia A. Ginger (Zingiber officinale Roscoe) and the gingerols inhibit the growth of Cag A+ strains of Helicobacter pylori. Anticancer research. 2003 Sep;23:3699
47)Bhandari U, Sharma JN, Zafar R. The protective action of ethanolic ginger (Zingiber officinale) extract in cholesterol fed rabbits. Journal of Ethnopharmacology. 1998 Jun 1;61(2):167-71.
48)Nurtjahja-Tjendraputra E, Ammit AJ, Roufogalis BD, Tran VH, Duke CC. Effective anti-platelet and COX-1 enzyme inhibitors from pungent constituents of ginger. Thrombosis research. 2003 Jan 1;111(4-5):259-65.
49) B. J Yates,1* A.D. Miller2 and J. B. Lucot3, “Department of otolaryngology and Neuroscience”,“Physiological basis and pharmacology of motion sickness” 28 April 1998.
50) Sharma Y. Ginger (Zingiber officinale)-an elixir of life a review. The Pharma Innovation. 2017 Nov 1;6(11, Part A):22.
51) Brown AC, Shah C, Liu J, Pham JT, Zhang JG, Jadus MR. Ginger's (Zingiber officinale Roscoe) inhibition of rat colonic adenocarcinoma cells proliferation and angiogenesis in vitro. Phytotherapy Research: An International Journal Devoted to Pharmacological and Toxicological Evaluation of Natural Product Derivatives. 2009 May;23(5):640-5.
52) Syafitri DM, Levita J, Mutakin M, Diantini A. A review: Is ginger (Zingiber officinale var. Roscoe) potential for future phytomedicine. Indonesian Journal of Applied Sciences. 2018 Apr 30;8(1):8-13.
53)Paulsen BS. Highlights through the history of plant medicine. Bioactive compounds in plants-benefits and risks for man and animals. 2010;50.
54)Li R, Reed DW, Liu E, Nowak J, Pelcher LE, Page JE, Covello PS. Functional genomic analysis of alkaloid biosynthesis in Hyoscyamus niger reveals a cytochrome P450 involved in littorine rearrangement. Chemistry & Biology. 2006 May 1;13(5):513-20.
55)Bernhoft AJ. A brief review on bioactive compounds in plants. Bioactive compounds in plants-benefits and risks for man and animals. 2010;50:11-7.
56)Begum Sajeli BS, Mahendra Sahai MS, Suessmuth R, Asai T, Hara N, Fujimoto Y. Hyosgerin, a new optically active coumarinolignan, from the seeds of Hyoscyamus niger.
Article Sidebar
Published
Dec 11, 2024
Article Details
How to Cite
Vatsal Rajput, Kuntupalli Sandhya Rani, & Dr. Pragnesh Patani. (2024). A REVIEW ON EXPLORING THE MEDICINAL VALUE OF ZINGIBER OFFICINALE AND HYOSCYAMUS NIGER TO PREVENT OR OVERCOME SEASICKNESS. Journal of Population Therapeutics and Clinical Pharmacology, 31(11), 1140-1150. https://doi.org/10.53555/1pszpb02
Section
Articles
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All articles published in JPTCP are licensed under Copyright Creative Commons Attribution-NonCommercial 4.0 International License.
Author Biographies
Vatsal Rajput
Student, Khyati College of Pharmacy, Palodia, Ahmedabad.Kuntupalli Sandhya Rani
Assistant Professor, Khyati College of Pharmacy, Palodia, AhmedabadDr. Pragnesh Patani
Principal and Professor, Khyati College of Pharmacy, Palodia, Ahmedabad
How to Cite
Vatsal Rajput, Kuntupalli Sandhya Rani, & Dr. Pragnesh Patani. (2024). A REVIEW ON EXPLORING THE MEDICINAL VALUE OF ZINGIBER OFFICINALE AND HYOSCYAMUS NIGER TO PREVENT OR OVERCOME SEASICKNESS. Journal of Population Therapeutics and Clinical Pharmacology, 31(11), 1140-1150. https://doi.org/10.53555/1pszpb02